Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

Sopharma Trading AD - Filing #6022492

Concept As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
As at
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Disclosure of effect of changes in foreign exchange rates [text block]
Disclosure of information when currency is not exchangeable into another currency [text block]
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]
Disclosure of summarised financial information about foreign operation [text block]
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets
168,393,000.000 BGN
178,510,000.000 BGN
Non-current liabilities
97,402,000.000 BGN
96,144,000.000 BGN
Current liabilities
400,557,000.000 BGN
443,447,000.000 BGN
Profit (loss)
- BGN
- BGN
- BGN
- BGN
- BGN
8,050,000.000 BGN
8,050,000.000 BGN
11,476,000.000 BGN
- BGN
11,476,000.000 BGN
- BGN
- BGN
- BGN
- BGN
Other comprehensive income
- BGN
- BGN
- BGN
8,000.000 BGN
87,000.000 BGN
88,000.000 BGN
9,000.000 BGN
68,000.000 BGN
- BGN
59,000.000 BGN
9,000.000 BGN
- BGN
- BGN
- BGN
Comprehensive income
- BGN
- BGN
- BGN
8,000.000 BGN
87,000.000 BGN
7,962,000.000 BGN
8,041,000.000 BGN
11,408,000.000 BGN
- BGN
11,417,000.000 BGN
9,000.000 BGN
- BGN
- BGN
- BGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.